[1] Siegel R,Ward E,Brawley O,et al.Cancer statistics,2011:the impact of eliminating socioeconomic and racial disparities on premature cancer deaths［J］.CA Cancer J Clin,2011,61(4):212－236.
[2] Kurman RJ,Shih IM.The origin and pathogenesis of epithelial ovarian cancer:a proposed unifying theory［J］.Am J Surg Pathol,2010,34(3):433－443.
[3] Seidman JD,Sherman ME,Bell KA,et al. alpingitis,salpingoliths,and serous tumors of the ovaries:is there a connection［J］.Int JGynecol Pathol,2002,21(2):101－107.
[4] Kindelberger DW,Lee Y,Miron A,et al.Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship［J］.Am J Surg Patho,2007,31(2) :161－169.
[5] 张惜阴,临床妇科肿瘤学［M］.2 版.上海:复旦大学出版社,2002:220.
[6] 董孟杰,赵葵,阮凌翔,等.FDG PET/CT 显像对复发性卵巢癌诊断价值的Meta分析［J］.中国医疗设备,2009,24(8):23－27.
[7] 刘若男.卵巢癌患者血清标志物CA125和临床病理的关系及其临床意义［J］.实用诊断与治疗杂志,2005,19(9) :637－638 .
[8] 彭娟,江庆萍，刘少颜． SOX4 和p53在卵巢浆液性乳头状癌中的表达及意义［J］.广东医学杂志,2012,33( 15):2313－2316.
[9] 侯锐,姜罗,刘大我,等.黏蛋白MUC1在卵巢浆液性肿瘤中的表达及其临床意义［J］.现代肿瘤医学,2012,20(6) :1250－1253.
[10] 郑庆玲,冯一中,顾栋桦,等. Fascin 在卵巢浆液性肿瘤中的表达及其临床意义［J］.江苏医药,2012,38(6):699－701.
[11] 黄琳玲,于晓红.B7-H1在卵巢浆液性囊腺癌中的表达及临床意义［J］.南昌大学学报,2012,52(8) :50－56.
[12] Brun JL,Feyler A,Chene G,et al.Long-term results and prognostic factor in patientswith epithelial ovarian cancer［J］.Gynecol Oncol,2000,7(8):21－27.
[13] 王珂,李文录.中晚期卵巢上皮癌长期存活及预后分析［J］.中华肿瘤防治杂志,2006,13(7):535－538.
[14] 杨蓉,冯婕,房祥忠,等.卵巢浆液性腺癌预后评分模型的建立及应用［J］.中华妇产科杂志,2006,7(4):459－463.